FDA Adverse Event Injury Summary report: N

WATCHMAN FLX?

MDR report key: 24885659 · Received April 15, 2026

Report

Report Number
2124215-2026-20320
Event Type
Injury
Date Received
April 15, 2026
Date of Event
June 18, 2025
Report Date
May 15, 2026
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NGV
UDI-DI
08714729860501
PMA / PMN Number
P130013
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Description of Event or Problem · 0

THE PATIENT WAS A PART OF A CLINICAL STUDY. IT WAS REPORTED A CEREBRAL VASCULAR ACCIDENT (CVA) OCCURRED. ON (B)(6) 2022, A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS PERFORMED AND A 27MM WATCHMAN FLX CLOSURE DEVICE WAS IMPLANTED WITH A COMPLETE LAA SEAL AND DEPLOYED DEVICE DIAMETER OF 22 MM. THE PATIENT WAS DISCHARGED THE SAME DAY ON ASPIRIN AND RIVAROXABAN. ON (B)(6) 2025, THE PATIENT PRESENTED TO AN OUTSIDE HOSPITAL AFTER A MOTOR VEHICLE ACCIDENT (MVA) FOR EXTENSIVE TREATMENT AND WAS DIAGNOSED WITH TRAUMATIC BRAIN INJURY IN RESPONSE TO THE MVA. AS A RESULT OF THE MVA, A MAGNETIC RESONANCE IMAGING (MRI) SCAN WAS PERFORMED WHICH ALSO REVEALED AN ACUTE BILATERAL ISCHEMIC STROKE WITH ONSET DATE OF JUNE 18, 2025, WHICH WAS 1211 DAYS POST RANDOMIZATION TO THE CLINICAL STUDY. A TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE) WAS PERFORMED AND WAS NEGATIVE FOR THROMBUS AND NEUROLOGY WAS CONCERNED FOR MICRO-EMBOLI, SO THE PHYSICIANS PLAN TO START THE PATIENT ON ELIQUIS ONCE STABLE. THE PATIENT WAS TREATED AND EVENTUALLY DISCHARGED TO A SKILLED NURSING FACILITY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
571756 WATCHMAN FLX? SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL NGV BOSTON SCIENTIFIC CORPORATION M635WU50270 0028751997 08714729860501

Patients

Seq Age Sex Outcome Treatment
1 74 YR Male Hospitalization| R